Literature DB >> 26034364

Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.

Min-Sun Kwak1, Donghee Kim1, Goh Eun Chung1, Won Kim1, Yoon Jun Kim1, Jung-Hwan Yoon1.   

Abstract

AIM: To investigate the relationship between gallstone disease and nonalcoholic fatty liver disease (NAFLD) in a large Asian population.
METHODS: A cross-sectional study including 17612 subjects recruited from general health check-ups at the Seoul National University Hospital, Healthcare System Gangnam Center between January 2010 and December 2010 was conducted. NAFLD and gallstone disease were diagnosed based on typical ultrasonographic findings. Subjects who were positive for hepatitis B or C, or who had a history of heavy alcohol consumption (> 30 g/d for men and > 20 g/d for women) or another type of hepatitis were excluded. Gallstone disease was defined as either the presence of gallstones or previous cholecystectomy, and these two entities (gallstones and cholecystectomy) were analyzed separately. Clinical parameters including body mass index, waist circumference, hypertension, diabetes, smoking status, and regular physical activity were reviewed. Laboratory parameters, including serum levels of gamma-glutamyl transpeptidase, alanine aminotransferase, aspartate aminotransferase, fasting glucose, fasting insulin, total cholesterol, triglycerides, and high-density lipoprotein, were also reviewed.
RESULTS: The mean age of the subjects was 48.5 ± 11.3 years, and 49.3% were male. Approximately 30.3% and 6.1% of the subjects had NAFLD and gallstone disease, respectively. The prevalence of gallstone disease (8.3% vs 5.1%, P < 0.001), including both the presence of gallstones (5.5% vs 3.4%, P < 0.001) and a history of cholecystectomy (2.8% vs 1.7%, P < 0.001), was significantly increased in the NAFLD group. In the same manner, the prevalence of NAFLD increased with the presence of gallstone disease (41.3% vs 29.6%, P < 0.001). Multivariate regression analysis showed that cholecystectomy was associated with NAFLD (OR = 1.35, 95%CI: 1.03-1.77, P = 0.028). However, gallstones were not associated with NAFLD (OR = 1.15, 95%CI: 0.95-1.39, P = 0.153). The independent association between cholecystectomy and NAFLD was still significant after additional adjustment for insulin resistance (OR = 1.45, 95%CI: 1.01-2.08, P = 0.045).
CONCLUSION: This study shows that cholecystectomy, but not gallstones, is independently associated with NAFLD after adjustment for metabolic risk factors. These data suggest that cholecystectomy may be an independent risk factor for NAFLD.

Entities:  

Keywords:  Cholelithiasis; Fatty liver; Gallbladder; Gallbladder removal; Hepatic steatosis

Mesh:

Year:  2015        PMID: 26034364      PMCID: PMC4445106          DOI: 10.3748/wjg.v21.i20.6287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

2.  Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

Authors:  Paola Loria; Amedeo Lonardo; Silvia Lombardini; Lucia Carulli; Annamaria Verrone; Dorval Ganazzi; Antonia Rudilosso; Roberto D'Amico; Marco Bertolotti; Nicola Carulli
Journal:  J Gastroenterol Hepatol       Date:  2005-08       Impact factor: 4.029

3.  Risk factors for conversion of laparoscopic cholecystectomy.

Authors:  Raffaele Costantini; Francesco Caldaralo; Carmela Palmieri; Luca Napolitano; Liberato Aceto; Carlo Cellini; Paolo Innocenti
Journal:  Ann Ital Chir       Date:  2012 May-Jun       Impact factor: 0.766

4.  Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Rosanna Lerza; Domenico Lapenna; Raffaele Costantini; Leonardo Vecchiet
Journal:  Pain       Date:  2005-01-26       Impact factor: 6.961

5.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

6.  Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?

Authors:  Flavio Nervi; Marco Arrese
Journal:  Am J Gastroenterol       Date:  2013-06       Impact factor: 10.864

Review 7.  Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?

Authors:  Mohamed H Ahmed; Asif Ali
Journal:  Scand J Gastroenterol       Date:  2014-03-20       Impact factor: 2.423

8.  Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study.

Authors:  Ji Cheol Bae; Eun Jung Rhee; Won Young Lee; Se Eun Park; Cheol Young Park; Ki Won Oh; Sung Woo Park; Sun Woo Kim
Journal:  Diabetes Care       Date:  2011-01-28       Impact factor: 19.112

Review 9.  KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2013-12-28

10.  Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Anna Alisi; Sara Ceccarelli; Nadia Panera; Federica Prono; Stefania Petrini; Cristiano De Stefanis; Marco Pezzullo; Alberto Tozzi; Alberto Villani; Giorgio Bedogni; Valerio Nobili
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more
  17 in total

Review 1.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

Review 2.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

3.  Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta-analysis: Reply.

Authors:  Sangchul Yun; Dongho Choi
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

4.  Association Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Meta-analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Suthinee Jaruvongvanich; Sikarin Upala
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

5.  Cholecystectomy: a way forward and back to metabolic syndrome?

Authors:  Gabriella Garruti; David Q-H Wang; Agostino Di Ciaula; Piero Portincasa
Journal:  Lab Invest       Date:  2018-01       Impact factor: 5.662

Review 6.  Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Sikarin Upala
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

7.  Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study.

Authors:  Víctor Cortés; Nicolás Quezada; Sergio Uribe; Marco Arrese; Flavio Nervi
Journal:  Lipids Health Dis       Date:  2017-06-30       Impact factor: 3.876

Review 8.  Gallstones in Patients with Chronic Liver Diseases.

Authors:  Xu Li; Xiaolin Guo; Huifan Ji; Ge Yu; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-01-31       Impact factor: 3.411

Review 9.  Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Authors:  Li Qi; Wanlin Dai; Jing Kong; Yu Tian; Yongsheng Chen
Journal:  J Physiol Biochem       Date:  2021-07-24       Impact factor: 4.158

10.  The Association Between Cholecystectomy and the Risk for Fracture: A Nationwide Population-Based Cohort Study in Korea.

Authors:  Eun Ji Lee; Cheol Min Shin; Dong Ho Lee; Kyungdo Han; Sang Hyun Park; Yoo Jin Kim; Hyuk Yoon; Young Soo Park; Nayoung Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.